Suppr超能文献

同一 ART 周期中严重少精子症患者使用睾丸精子和射出精液行 ICSI 辅助妊娠的结局分析:病例报告。

Outcome analysis of ICSI assisted pregnancy using testicular sperm versus ejaculated sperm in man with severe oligozoospermia in the same ART cycle: A case report.

机构信息

Department of Reproductive Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

Medicine (Baltimore). 2023 Feb 3;102(5):e32833. doi: 10.1097/MD.0000000000032833.

Abstract

RATIONALE

Intracytoplasmic sperm injection (ICSI) has become the most common method for couples with male factor infertility, and source of sperm for the procedure have evolved over time. but few have examined testicular sperm extraction vs. ejaculated sperm use for severe oligozoospermia in the same assisted reproductive technology (ART) cycle.

PATIENT CONCERNS

Here, we evaluated the clinical outcomes after ICSI with testicular sperm or ejaculated in man with severe oligozoospermia in the same ART cycle. A couple who had failed the first ART cycle with ejaculated sperm, using the freshly ejaculated sperm and testicular sperm for ICSI during the second ART cycle by lack of enough sperm to fertilize in an ICSI attempt.

DIAGNOSES

The patient was diagnosed with severe oligozoospermia, and routine semen analysis revealed sperm concentration is less than 2 million/mL.

INTERVENTIONS

The patient using testicular sperm versus ejaculated sperm with ICSI assisted pregnancy in the same ART cycle.

OUTCOMES

We found that superior cleavage rate, number of embryos transferred and blastocyst rate with the use of testicular rather than ejaculated sperm-ICSI in the couple. The results described here suggest that use of testicular sperm may improve biologic outcomes, especially for couples with male-partner oligozoospermia who previous ICSI failures.

LESSONS

Our case report supported the efficacy of testicular sperm preference over ejaculated sperm for ICSI in men with severe male factor infertility. It is a paradigm shift concerning the use of ejaculated sperm as the preferable source of sperm for ICSI, add to the small amount of literature on testicular sperm extraction vs. ejaculated sperm use for severe oligozoospermia in the same ART cycle.

摘要

背景

卵胞浆内单精子注射(ICSI)已成为男性因素不育夫妇最常用的方法,并且用于该过程的精子来源随着时间的推移而不断发展。但是,很少有研究在同一辅助生殖技术(ART)周期中检查睾丸精子提取与射出精子在严重少精子症中的应用。

患者关注

在这里,我们评估了在同一 ART 周期中使用睾丸精子或射出精子进行严重少精子症的 ICSI 的临床结局。一对夫妇在第一次 ART 周期中使用射出精子失败后,由于缺乏足够的精子用于 ICSI 尝试受精,因此在第二次 ART 周期中使用新鲜射出精子和睾丸精子进行 ICSI。

诊断

患者被诊断为严重少精子症,常规精液分析显示精子浓度小于 200 万/mL。

干预措施

患者在同一 ART 周期中使用睾丸精子与射出精子进行 ICSI 辅助妊娠。

结果

我们发现,与使用射出精子-ICSI 相比,使用睾丸精子可提高卵裂率、胚胎移植数量和囊胚率。这里描述的结果表明,对于以前 ICSI 失败的男性因素少精子症夫妇,使用睾丸精子可能会改善生物学结局。

教训

我们的病例报告支持在严重男性因素不育的男性中,使用睾丸精子优于射出精子进行 ICSI。这是关于使用射出精子作为 ICSI 首选精子来源的范式转变,增加了关于在同一 ART 周期中睾丸精子提取与射出精子在严重少精子症中的应用的少量文献。

相似文献

4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验